Work

Abstract PS5-10-24: Cardiac Monitoring in Patients Receiving HER2-Directed Therapy: A Meta-Analysis and Cost-Effectiveness Analysis

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-10-24

Authors: I. Schlam, M. C. Saad Menezes, J. N. Upshaw, J. Rabinowitz, J. Schwartz, A. Julian, V. Mico, S. Papatheodorou, N. Kunst, A. Pandya, A. Barac, S. M. Tolaney

Institutions: Dana-Farber Cancer Institute, The University of Texas Southwestern Medical Center, Beth Israel Deaconess Medical Center, Tufts University, Tufts Medical Center, Rutgers, The State University of New Jersey, York University, University of York, Harvard University

Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129340400

Cites:

Cited by:

Related to: